Clinical safety of tocilizumab in rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Clinical safety of tocilizumab in rheumatoid arthritis.

Clinical safety of tocilizumab in rheumatoid arthritis.

http://www.wikidata.org/entity/Q37814417

about

Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies γ-Tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/EBPβ and NF-κB in macrophages Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis.Safety of biologic therapy in rheumatoid arthritis.Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis.Treat-to-target: a tailored treatment approach to rheumatoid arthritis.Cytochrome P450 interactions and clinical implication in rheumatology.Atacicept as an investigated therapy for rheumatoid arthritis.Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.A new alternative therapy in dermatology: tocilizumab.Disentangling the effects of tocilizumab on neutrophil survival and function.

P2860

Q26830569-3D7C7A18-860A-4754-A975-020701B278AA Q33998131-A5DC1B38-3CFE-40D2-B800-4E964CADC7CB Q35863952-1ACBAEF9-1B55-445B-B78E-FFD7FE125937 Q36724490-6CF91AB5-609F-49D5-A31C-F559F39AA1D0 Q37372691-2C69CA34-C0CE-4B67-9A50-1196B7B7BA87 Q37944433-685DF9D1-B013-4D10-B816-B81C5866A646 Q38053174-970F2B71-ADBA-42E4-963A-9449EA665445 Q38097494-5B177569-A5F0-469D-BA94-B848EBF68B52 Q38125456-420B1CC1-F3A2-4ADF-9DFC-B6F2CF8DFFB4 Q38219868-9DBDABB5-6E5F-4C47-94E0-B32CBF3931E5 Q38235570-00BF2FBC-DB5C-42F5-B87E-8E551B281F27 Q38285827-59930954-7FA0-4626-9C85-E4A6D716EF78 Q38507301-4402986C-3AA5-45B2-BD93-652CAC9B1E39 Q48044670-D506B6F5-7E0A-48F3-B85C-BE6791C4EE17

P2860

Clinical safety of tocilizumab in rheumatoid arthritis.

http://www.wikidata.org/entity/Q37814417

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinical safety of tocilizumab in rheumatoid arthritis.

@en

Clinical safety of tocilizumab in rheumatoid arthritis.

@nl

type

label

Clinical safety of tocilizumab in rheumatoid arthritis.

@en

Clinical safety of tocilizumab in rheumatoid arthritis.

@nl

prefLabel

Clinical safety of tocilizumab in rheumatoid arthritis.

@en

Clinical safety of tocilizumab in rheumatoid arthritis.

@nl

P1433

Q37814417-9671C07A-E07F-401E-8928-F5F510616611

P1476

Q37814417-34B07624-BB17-4D85-A334-9811C316F1C9

P2093

Q37814417-9800EF6A-27B4-46F7-8DF2-09E09E48D982

Q37814417-F7FF59B8-EAB1-4574-9FFA-6544EADCE08B

P2860

Q37814417-16818CC0-1CBB-4BC6-AD3A-0AF21FA0E68E

Q37814417-16B52558-E6C1-40EB-B2C8-367F062DCF87

Q37814417-1AFAACAE-282E-49A8-9689-DD71B2A12179

Q37814417-1B98D1F7-F620-45A8-AA3D-FB08C975FC5F

Q37814417-200E3DDA-5D9E-4D72-BA77-591AAE40D5E0

Q37814417-336703E9-1935-4271-8F79-474EE64B5B9A

Q37814417-4449F751-D193-4388-AEF1-8F5103239106

Q37814417-47B0CCE5-F136-4AE8-A659-4884336DAFE7

Q37814417-6B60A142-796E-4626-A31F-CBA262B3C5E8

Q37814417-6F2B084A-73EA-477F-A463-AFF6E0F5A419

P304

Q37814417-867F9947-ABB1-4577-9609-6DF853C19D60

P31

Q37814417-FEDCB88B-8022-4F22-AA92-0C63A7761FBE

Q37814417-e9c90011-8b18-4e7d-8b50-4da843e8c45e

P356

Q37814417-1DE2E514-1182-492C-9B31-D6E499D12D7B

P407

Q37814417-14060433-0830-48F3-9A6D-6F6467EB2E6B

P433

Q37814417-F334A644-AD31-44AF-821C-5B02D36059DB

P478

Q37814417-55E33851-2C1E-45F4-89B6-29B9D2307AB2

P577

Q37814417-1A0B38F8-5CB6-4BA7-B02D-AF6180C04067

P698

Q37814417-4D9D45C8-324F-4524-92C0-08B263C3824D

P356

14740338.2011.537256

P1433

Expert Opinion on Drug Safety

P1476

Clinical safety of tocilizumab in rheumatoid arthritis.

@en

P2093

Bernard Bannwarth

http://www.w3.org/2001/XMLSchema#string

Christophe Richez

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

Tocilizumab: a review of its use in the management of rheumatoid arthritis

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic dr

The addition of tocilizumab to DMARD therapy for rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Benefits and risks of drug treatments: how to combine the best evidence on benefits with the best data about adverse effects.

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Interleukin-6 and its receptor in cancer: implications for translational therapeutics.

Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.

Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?

Treatment of rheumatoid arthritis: state of the art 2009.

P304

123-131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2011.537256

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21121872

http://www.w3.org/2001/XMLSchema#string